An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) will release its financial results for Q4 and full year 2023 on February 15, 2024. The management will discuss the results in a conference call on the same day. Investors can access the call via phone or live webcast. A replay will be available for up to a year.
Positive
None.
Negative
None.
HERCULES, Calif.--(BUSINESS WIRE)--
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year 2023 on Thursday, February 15, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
To participate, dial 888-259-6580 within the U.S. or +1 416-764-8624 outside the U.S., access code: 36826276. A live webcast of the conference call will also be available in the "Investor Relations" section of the company’s website under "Events & Presentations" at investors.bio-rad.com. A replay of the webcast will be available for up to a year.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with over 8,200 employees and $2.8 billion in revenues in 2022. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.
Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com
Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
pr@bio-rad.com
Source: Bio-Rad Laboratories, Inc.
FAQ
When will Bio-Rad Laboratories release its financial results for Q4 and full year 2023?
Bio-Rad Laboratories will release its financial results on February 15, 2024.
How can investors participate in the conference call?
Investors can participate in the conference call by dialing 888-259-6580 within the U.S. or +1 416-764-8624 outside the U.S. with access code: 36826276.
Where can investors access the live webcast of the conference call?
Investors can access the live webcast in the 'Investor Relations' section of the company’s website under 'Events & Presentations' at investors.bio-rad.com.
How long will the replay of the webcast be available?
The replay of the webcast will be available for up to a year.
